MiniMed Group, Inc.(MMEDV)

Medical - Instruments & Supplies · Northridge, CA

$20.000.00 (0.00%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T19:02:36.180Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:02:36.180Z.

Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 20
Unrounded diluted TTM EPS: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

MMEDV PE Ratio Metrics

PE RATIO

N/A

MMEDV Competitors' PE Ratio

MMEDV

MiniMed Group, Inc.

Current

Market Cap

$560.00M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTMX

CytomX Therapeutics, Inc.

vs MMEDV

Market Cap

$561.67M

PE Ratio

N/A

TTM Avg

80.35

3Y Avg

49.81

5Y Avg

49.81

CRMD

CorMedix Inc.

vs MMEDV

Market Cap

$569.77M

PE Ratio

3.41

TTM Avg

5.18

3Y Avg

15.60

5Y Avg

15.60

MNPR

Monopar Therapeutics Inc.

vs MMEDV

Market Cap

$548.99M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PHAT

Phathom Pharmaceuticals, Inc.

vs MMEDV

Market Cap

$542.44M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STTK

Shattuck Labs, Inc.

vs MMEDV

Market Cap

$541.33M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AQST

Aquestive Therapeutics, Inc.

vs MMEDV

Market Cap

$579.03M

PE Ratio

N/A

TTM Avg

506.15

3Y Avg

506.15

5Y Avg

506.15

PROK

ProKidney Corp.

vs MMEDV

Market Cap

$536.32M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NVCT

Nuvectis Pharma, Inc.

vs MMEDV

Market Cap

$534.18M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FLGT

Fulgent Genetics, Inc.

vs MMEDV

Market Cap

$583.63M

PE Ratio

N/A

TTM Avg

4.23

3Y Avg

40.60

5Y Avg

40.60

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
MiniMed Group, Inc. (MMEDV)	$560.00M	N/A	N/A	N/A	N/A
CytomX Therapeutics, Inc. (CTMX)vs ›	$561.67M	N/A	80.35	49.81	49.81
CorMedix Inc. (CRMD)vs ›	$569.77M	3.41	5.18	15.60	15.60
Monopar Therapeutics Inc. (MNPR)vs ›	$548.99M	N/A	N/A	N/A	N/A
Phathom Pharmaceuticals, Inc. (PHAT)vs ›	$542.44M	N/A	N/A	N/A	N/A
Shattuck Labs, Inc. (STTK)vs ›	$541.33M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$579.03M	N/A	506.15	506.15	506.15
ProKidney Corp. (PROK)vs ›	$536.32M	N/A	N/A	N/A	N/A
Nuvectis Pharma, Inc. (NVCT)vs ›	$534.18M	N/A	N/A	N/A	N/A
Fulgent Genetics, Inc. (FLGT)vs ›	$583.63M	N/A	4.23	40.60	40.60

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

MMEDV PE Ratio Metrics

MMEDV Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics